KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to 18.81%.

  • Medtronic's EBIT Margin fell 1700.0% to 18.81% in Q4 2025 from the same period last year, while for Oct 2025 it was 17.88%, marking a year-over-year increase of 14800.0%. This contributed to the annual value of 17.76% for FY2025, which is 18600.0% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's EBIT Margin is 18.81%, which was down 1700.0% from 16.85% recorded in Q3 2025.
  • Medtronic's 5-year EBIT Margin high stood at 21.37% for Q1 2022, and its period low was 10.75% during Q3 2021.
  • For the 5-year period, Medtronic's EBIT Margin averaged around 17.47%, with its median value being 18.16% (2023).
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 143300bps in 2021, then crashed by -60500bps in 2024.
  • Quarter analysis of 5 years shows Medtronic's EBIT Margin stood at 19.92% in 2021, then fell by -7bps to 18.51% in 2022, then decreased by -9bps to 16.78% in 2023, then increased by 13bps to 18.98% in 2024, then decreased by -1bps to 18.81% in 2025.
  • Its last three reported values are 18.81% in Q4 2025, 16.85% for Q3 2025, and 16.09% during Q2 2025.